E10.43
Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy
Clinical Classification Guidelines
Inclusion Terms
- Type 1 diabetes mellitus with diabetic gastroparesis
Medical Intelligence & Overview
Type 1 diabetes mellitus with diabetic autonomic neuropathy, specifically diabetic gastroparesis, is a complication that can develop in individuals living with type 1 diabetes. This condition involves damage to the nerves that control involuntary bodily functions, particularly impacting the digestive system. Recognizing and managing this condition is essential for maintaining overall health and quality of life.
Causes & Symptoms
Clinical Causes: Chronic high blood sugar levels over time can damage nerve fibers throughout the body. Persistent hyperglycemia leading to oxidative stress and inflammation, contributing to nerve damage. Genetic factors may influence individual susceptibility to nerve complications from diabetes. Duration of diabetes: Longer periods of poorly controlled blood sugar increase risk. Presence of other diabetic complications, such as kidney disease, can exacerbate nerve damage.
Key Symptoms: Nausea or vomiting, especially after meals. Feeling full quickly during eating, leading to decreased appetite. Unintended weight loss due to poor digestion. Bloating and abdominal discomfort. Erratic blood glucose levels due to unpredictable gastric emptying. In some cases, altered heart rate or blood pressure regulation.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical exams, and specialized tests, such as:
Treatment Protocols: While there is no cure for diabetic autonomic neuropathy, management strategies focus on alleviating symptoms and controlling blood sugar levels. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is E10.43 a billable ICD-10 code?
Yes, E10.43 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E10.43?
Clinical documentation must specify the nature of Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference